• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Antibiotic A42125, which is produced by a new strain of Nocardia aerocolonigenes, NRRL 18049, is a useful inhibitor of Gram-positive and methane-generating microorganisms. A42125 also increases feed utilization efficiency in ruminants. A biologically purified culture of N. aerocolonigenes NRRL 18049 and a method for producing A42125 by fermentation of this culture are provided.
    公开号:SU1547710A3
    申请号:SU874202303
    申请日:1987-04-07
    公开日:1990-02-28
    发明作者:Л.Хэмилл Роберт；Эмиль Кастнер Ральф
    申请人:Эли Лилли Энд Компани (Фирма)；
    IPC主号:
    专利说明:

    This invention relates to the microbiological industry, in particular the production of antibiotics,
    Antibiotic A 42125 exhibits antimicrobial activity against microorganisms producing methane. The antibiotic increases the efficiency of nutrition, promotes the growth of ruminants.
    The antibiotic producer is the strain Nocardia aerocolonigenes A 42125, which is isolated from a soil sample from Brazil. The strain is deposited under the number NRRL 18049 and is characterized by the following features.
    Cultural and morphological signs,
    The culture produces an extensive substrate and a well-developed aerial
    mycelium. Air hyphae have a web appearance. Conidia are observed by scanning electron microscopy. Spores are formed weakly and irregularly. Ornamentation of the surface of the dispute is smooth. The shape of the spores from oblong to cylindrical form chains of more than 50 units. The size of the spores varies from 1.2-0.9 x 0.5-0.4 microns, on average 1.1 x x 0.5 microns. Under deep growth conditions with shaking, hyphae split into fragments.
    MPS2 medium - abundant growth, substrate mycelium 78.d.yBrI (hereinafter the color is given in the Tresner and Bachus system); aerial mycelium abundant, 5fel.gy.rBn. Soluble pigment is light brown.
    sd
    1 J
    Wednesday MPSA - good growth, substrate mycelium 89.p.Y4; aerial mycelium abundant, b, pearl white. Soluble pigment is missing,
    Wednesday MPS4 - good growth; substrate mycelium 77.rn.yBr; aerial mycelium is good, light gray. Soluble pigment is missing.
    The environment of the MPSP is abundant; substrate mycelium 77, m.yBr5; aerial mycelium abundant, pearl white. Soluble pigment is missing.
    Calcium malate is a good growth; substrate mycelium 77.rn.yBr; aerial 15 mycelium good, b, pearl white. Soluble pigment is missing.
    Capar agar - good growth; substrate mycelium 77.rn.yBr; aerial mycelium good, d, light-20 gray. Soluble pigment is slightly light brown.
    Glkzozo-aspartic medium - good growth; substrate mycelium 89, p.Y; (Aerial mycelium is poorly developed, d, 25 is light gray. There is no soluble pigment.
    Tap water agar - good growth, substrate mycelium 92.u white 8; aerial mycelium abundant, 30 | b, pearl-white "Soluble pigment is absent,
    i Yeast-dextrose agar - growth abundant, substrate mycelium 78, d.Br; aerial mycelium is not developed (wrinkled surface.). Soluble pigment is light brown.
    Physiological and biochemical properties.
    Decomposes casein, elastin, guanine, gkpoksantin, tyrosine, 40
    Hydrolyzes calcium malate, DNA, esculin and starch.
    Ferments up to arabinose, cellobiose, fructose, galactose, cf- 45 methyl-D-glycoside, glucose, glycerin, inositol, lactose, maltose, mannitol, mannose, melibiosis, raffinose, rhamnose, trehalose, xylose.
    It utilizes acetate, benzoate, cit-, -Q rat, malate, oxalate, propionate, pyruvate, succinate and tartrate.
    Produces catalase, phosphatase, proteinau, urease, melanoid pigments, g
    Resistant to NaCl concentration up to 6%.
    Hydrolyzes latex without cream.
    Restores nitrates to nitrites.
    It grows at a temperature of 15 to 37 ° C, dies when exposed to a temperature of 50 ° C for 8 hours.
    Resistant to lysozyme, cephalotin, gentamicin, lincomycin, penicillin and tobramycin, sensitive to rifampin.
    The method of producing antibiotic A 42125 is illustrated by the following examples.
    Example 1. Antibiotic biosynthesis.
    The strain Nocardia aerocolonigenes NRRL 18049, in the form of a lyophilized granule or suspension, stored in liquid nitrogen, is sown on a slant agar of the following composition, g / l: Potato dextrin 10 Yeast extract 1 Enzymatic casein hydrolyzate 2 Mecane extract 1 Codr, 6, 6, 6, 0.6, 6, 196 Deionized -. water, l1
    The pH is adjusted from 6.2 to 7.0 with NaOH solution.
    Inoculated beveled agar is incubated at 30 ° C for 7 days. Mature culture on oblique agar is scraped with a sterile tool to loosen the spores and extract and macerate the mycelial film. About 1/4 of the loosened spores and the culture thus obtained are used to inoculate 50 ml of a vegetative medium having the following composition, g / l: Glucose15
    Manicure dextrin 20 Corpse of soybean culture 1 5 Corn meresting liquid 10 Yeast extract 1 Cac03 2 Tap water, l 1 Inoculated vegetative media are incubated in 250 ml Erlenmeyer flask at 30 C for approximately 72 hours on a shaker at 250 rpm.
    This incubated vegetative medium (1.25 ml) is used to inoculate 50 ml of production medium having the following composition, g / l: Glucose25
    Corn Starch 10
    ten
    4 5
    0.5 2.0
    one
    51
    Soluble Meat
    peptone
    Enzymatic hydrolysis of casein
    Cheese molasses
    MgSCV 7H20
    Cac03
    Mineral mixture
    Capek jr
    Deionized in,
    Yes l
    The mineral mixture of čapek has the following composition: 100 g of KC1, 100 g of MgS04 7H.jO, 2 g of FeS04-7H40, up to 1 deionized water.
    The inoculated production medium is incubated in a 250 ml wide-mouth Erlenmeyer flask at 30 ° C for a period of 3 to 5 days on a shaker at a speed of 250 rpm.
    In order to obtain a large v inoculum volume, 10 ml of the incubated vegetative medium, prepared as described above, is used to inoculate 250 ml of a two-stage growth medium having the same composition as the vegetative medium. This two-stage medium is incubated in a 2-liter wide-neck Erlenmeyer flask for approximately 70 hours at 30 ° C on a rocking chair at a speed of 250 rpm
    The incubated two-step medium (400 ml) thus obtained is used to inoculate 100 liters of sterile production medium, prepared as described above. The fermentation is carried out in a 165-liter fermentation tank for a period of 3 to 5 days at 30 ° C under stirring conditions. Low air flow (0.12 - 0.25 rev / min) and moderate rotation speed (200-250 rev / min) in the mixer maintain the level of dissolved oxygen 30% higher than air flow.
    Example 2. The selection of the antibiotic And 42125.
    The whole fermentation broth (92 L containing 3% Hyflo Supercel, filtered through a filter press. The broth filtrate (74 L) was adjusted to pH 7 with NaOH. The Diaon HP-20 resin (9.4 L) was added. The mixture was stirred within 45 minutes and filtered. The filtrate is removed and the resin is washed 3 times with water (each time 10 l) and three times with a mixture of acetopitrile water (each time 10 l), resuspendable,
    ten
    77
    15
    20
    five
    0
    five
    0
    five
    0
    five
    106
    remeshiva and filter. Washings are removed. And 42125 elute, suspendiruyu, the resin in a mixture of acetonitrile (1: 1, 10 l), mixing and filter. Four consecutive eruptions were performed, and each eluate fraction was analyzed using the Micrococcus luteus disc method to quantify the antibiotic. The first two eluates are combined, concentrated in vacuo to remove acetonitrile, and freeze dried to obtain 94.9 g of crude A 42125. From the third eluate, 20.8 g of crude A 42–25 are obtained.
    Example 3 Purification and crystallization of A 42125.
    The crude preparations A 42125 obtained in Example 2 were combined (115.2 g) and dissolved in water (3 L). The solution is filtered to remove a precipitate and the filtrate is fed to a column containing 3 liters of Dowex 50 x 2 (NH), 100-200 mesh resin. The column is washed successively with five volumes of a column of water and 0.1N. NH4OH solution. Fractions from elution 2 n. The MNPs containing the largest amounts of A 42125 are combined and concentrated to a volume of about 3 liters. P 42125 are precipitated and separated by filtration. The precipitate was dissolved in methanol (300 ml) and this solution was added to ether (6 L) to precipitate A 42125. This precipitate was filtered and dried to give 16.6 g A 42125 as an amorphous powder. The second precipitate is obtained by subsequent concentration of the aqueous solution and processing it in a similar way to obtain 20.7 g of less pure A 42125.
    The first A 42125 (16.6 g) is dissolved in warm water (800 ml). This solution is settled overnight at room temperature and A 42125 crystallizes. The crystals are separated by filtration and dried under vacuum to obtain 10.6 g and 2.3 g (second collection) of crystalline A 42125.
    Antibiotic characteristic.
    State: white crystals (out of water).
    M.p .: 149-150s.
    UV: no absorption.
    IR (CVH): shows absorption at the following frequencies () - a broad peak, which includes 3423, 3413, 3409, 3403, 3398 and 3386; 2937, 1720, 1602, 1453, 1408, 1379, 1290, 1192,
    1120, 1090, 1064, 971, 870, 830 and 802.
    Titration (80% aqueous dimethylformamide): degrees of acidity 5.2, 8.7 and 10.5.
    Mol. Mass: 2032 (field desorption mass spectrometry).
    Empirical formula: С 101К (g4N2U3,
    Elementary analysis: carbon 59.51, hydrogen 9.05, nitrogen 1.44, oxygen 30.08.
    Amino acids are not detected.
    Solubility: soluble in water.
    Bioautography: using Whatman paper number 1, impregnated with 0.95 N Na., S04 and NaHSO ,,, system
    solvent - 80% aqueous ethanol, containing 1.5% NaCl, using a Microcoecus luteus test culture, found that Rf is approximately 0.46.
    Based on the titration characteristics, the antibiotic may contain a carboxyl group, a phenolic group, which can form sodium, potassium,, lithium, cesium, rubidium, barium, calcium and magnesium salts; ammonium, primary, secondary and tertiary C-C-alkyls of monium and hydroxy-Cr-C4 alkylammonium; additive salts formed by standard reactions with both organic and inorganic acids.
    For livestock feed, not only a pure antibiotic can be used, but also all the culture liquid without extraction or separation, after the separation of water, i.e. dehydrated culture fluid. Dried in different ways, the culture fluid is mixed with nutrient premix
    PRI me R 4. The diet of large cattle, enhanced A 42125.
    A balanced, high-grain diet for livestock that is ready for processing is obtained according to the following recipe,%: Corn, yellow 50.25 Corn cobs 34,927 Lucerne flour, dehydrated, 17% 4.00
    Soybean meal, extracted with solvent Urea, feed grade Molasses reed and sugar Dicalcium phosphate Salt Calcium carbonate Microelement mineral premix Premix Vitamin A and d Premix Vitamin A Antibiotic A 42125
    100.00
    The trace element mineral premix contains,%: 2.50 manganese in the form of manganese oxide, 0.07 iodine in the form of potassium iodide, 0.03 cobalt in the form of cobalt carbonate, 0.5 copper in the form of copper oxide and 20 zinc in the form of zinc sulfate.
    权利要求:
    Claims (3)
    [1]
    1. Method of producing antibiotic A 42125, which consists in the fact that the strain NocardHa aerocolonigenes NRRL
    18049 are cultivated under anaerobic deep conditions with stirring in a nutrient medium containing a source of carbon and nitrogen and a mineral salt, followed by isolation of the desired product from the culture fluid.
    [2]
    2. The method according to claim 1, characterized in that, in order to obtain a pure preparation, the culture fluid is filtered, and the filtrate is subjected to extraction and the target product is purified by chromatography.
    [3]
    3. Strain of the microorganism Nocardia aerocolonigenes NRRL 18049 - producer of the antibiotic A 42125.
    类似技术:
    公开号 | 公开日 | 专利标题
    CA1174622A|1984-09-18|Enzyme inhibitor produced by cultivation ofstreptomyces microorganisms
    EP0132082A2|1985-01-23|Antibiotic/antitumor compounds and their production
    US5278052A|1994-01-11|Process for the simultaneous production of benanomicins A and B
    US5081023A|1992-01-14|Antibiotic l53-18a and process for preparation thereof
    SU1547710A3|1990-02-28|Method of producing antibiotic a 42125 and strain of nocardia aerocolonigenes microorganism as producer of antibiotic a 42125
    EP0298640B1|1992-08-19|A new antimicrobial agent, fr 109615 and production thereof
    US4548974A|1985-10-22|Antibiotics produced by Kibdelosporangium aridum shearer
    US4918054A|1990-04-17|Antibiotics called `chloropolysporins B and C`, a process for their preparation, and their therapeutic and veterinary use
    CA1270782A|1990-06-26|Cl-1577d and 1577e antibiotic/antitumor compounds,their production and use
    US5223413A|1993-06-29|Process for the preparation of vancomycin
    US4954641A|1990-09-04|Novel antitumor antibiotic substance and a method for production thereof
    US3950514A|1976-04-13|Antibiotic TM-481 derived from microorganism of the streptomyces ribosidificus group
    US4792522A|1988-12-20|Rigolettone antitumor complex
    US4764602A|1988-08-16|Antibiotics, and their production
    US4293546A|1981-10-06|Anthracycline antibiotics produced by Streptosporangium fragilis Shearer sp. nov. ATCC 31519
    US4110435A|1978-08-29|Antibiotic a-28086 factor d and process for production thereof
    EP0235795B1|1991-09-04|Antibiotic f-0769, process for its production, and its use as a growth accelerating and feed efficiency increasing agent and as an antitumour agent
    US4110436A|1978-08-29|Antibiotic a-28086 factor d and process for production thereof
    US4927810A|1990-05-22|Efomycin G and it's use as yield promoter in animals
    US4292309A|1981-09-29|Antibiotics C-14482 B1, B2 and B3
    US3932619A|1976-01-13|Metabolite A-27106 and processes for its preparation and use
    US4526866A|1985-07-02|Angiotensin I-converting enzyme inhibitor and preparation of the same
    US4003902A|1977-01-18|Naphthyridinomycin antibiotics
    JP3107455B2|2000-11-06|New antibiotic MI481-42F4-A and method for producing the same
    US4672036A|1987-06-09|Pure cultures of Kibdelsporangium aridum Shearer gen. nov., sp. nov. ATCC 39323 and mutants thereof
    同族专利:
    公开号 | 公开日
    US4870021A|1989-09-26|
    DK178387D0|1987-04-08|
    DE3779946T2|1993-01-14|
    PT84628B|1989-11-30|
    CN87102770A|1987-12-16|
    EP0241285A2|1987-10-14|
    ATA257387A|1989-07-15|
    KR870010178A|1987-11-30|
    JPS62281889A|1987-12-07|
    IL82119D0|1987-10-30|
    PT84628A|1987-05-01|
    NZ219902A|1989-01-27|
    EG18187A|1992-11-30|
    AU598531B2|1990-06-28|
    DE3779946D1|1992-07-30|
    AT389893B|1990-02-12|
    ZA872500B|1988-11-30|
    KR920003666B1|1992-05-06|
    US4764510A|1988-08-16|
    AU7136887A|1987-10-15|
    EP0241285B1|1992-06-24|
    EP0241285A3|1988-09-07|
    DK178387A|1987-10-12|
    CA1265462A|1990-02-06|
    GR3005027T3|1993-05-24|
    IE59699B1|1994-03-23|
    DK166024B|1993-03-01|
    HUT46073A|1988-09-28|
    DK166024C|1993-07-12|
    HU197941B|1989-06-28|
    IE870942L|1987-10-11|
    PH24808A|1990-10-30|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US4237224A|1974-11-04|1980-12-02|Board Of Trustees Of The Leland Stanford Jr. University|Process for producing biologically functional molecular chimeras|
    US4552842A|1983-01-28|1985-11-12|Bristol-Myers Company|Process for producing rebeccamycin|
    US4487925A|1983-01-28|1984-12-11|Bristol-Myers Company|Rebeccamycin and process for its preparation|
    US4524145A|1984-09-04|1985-06-18|Bristol-Myers Company|4'-Deschlororebeccamycin pharmaceutical composition and method of use|HU193294B|1984-08-15|1987-09-28|Gyogyszerkutato Intezet|Preparation influencing the digestion of ruminants advantageously|
    GB8618445D0|1986-07-29|1986-09-03|Lepetit Spa|Antibiotic a 42867|
    AT262349T|1993-10-19|2004-04-15|Commw Scient Ind Res Org|METHOD FOR IMPROVING THE FOOD RECOVERY OF Ruminants or Ruminant-Like Animals|
    DE19608263A1|1996-03-04|1997-09-11|Basf Ag|Ensiling agent|
    CN103088068A|2011-11-04|2013-05-08|天津绿动植物营养技术开发有限公司|Preparation method and application of soil rare actinomyces broth|
    JP5801344B2|2013-05-07|2015-10-28|ドーサン・フィード・アンド・ライブストック・カンパニーリミテッドＤｏｏｓａｎ Ｆｅｅｄ ＆ Ｌｉｖｅｓｔｏｃｋ Ｃｏ．， Ｌｔｄ．|Microorganisms capable of inhibiting methanogenesis in the rumen of ruminants and their use|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US06/850,786|US4764510A|1986-04-11|1986-04-11|Antibiotic A42125 and process for its production|
    [返回顶部]